Subjective Cognitive and Communicative Complaints and Health-Related Quality of Life in Parkinson's Disease with and without Mild Cognitive Impairment.

INTRODUCTION: Mild Cognitive Impairment (MCI) is common in Parkinson's Disease (PD). Few studies have compared the Health-Related Quality of Life (HRQoL) in patients with and without MCI due to PD (PD-MCI), and its correlation to patients' subjective cognitive and communicative difficulties has not been explored. OBJECTIVE: We aimed to compare HRQoL in PD-MCI and PD without MCI (PD-nMCI), and explore its possible relationship to subjective cognitive and communicative complaints. METHODS: We included 29 PD-nMCI and 11 PD-MCI patients. The HRQoL was assessed with the Parkinson's Disease Questionnaire-39 (PDQ-39): its Cognition dimension was used as a measure of subjective cognitive complaints, its Communication dimension for subjective communicative complaints, and the summary index (PDQ-39 SI) as an indicator of HRQoL. Non-parametric partial correlations between the Cognition and Communication dimensions, and the adjusted PDQ-39 SI were conducted. RESULTS: PD-MCI patients had greater subjective cognitive and communicative complaints and worse HRQoL than PD-nMCI patients. In the PD-MCI group, both subjective cognitive and communicative complaints exhibited significant direct correlations with the adjusted HRQoL scores. CONCLUSIONS: HRQoL seems to be affected in PD-MCI, and it might be influenced by greater subjective cognitive and communicative complaints. Including patient-reported outcome measures of HRQoL, and providing cognitive and speech rehabilitation, as well as psychotherapeutic strategies to face these deficits can enhance the patient-centred approach in PD.

Subjective Cognitive and Communicative Complaints and Health-Related Quality of Life in Parkinson's Disease with and without Mild Cognitive Impairment.

INTRODUCTION: Mild Cognitive Impairment (MCI) is common in Parkinson's Disease (PD). Few studies have compared the Health-Related Quality of Life (HRQoL) in patients with and without MCI due to PD (PD-MCI), and its correlation to patients' subjective cognitive and communicative difficulties has not been explored. OBJECTIVE: We aimed to compare HRQoL in PD-MCI and PD without MCI (PD-nMCI), and explore its possible relationship to subjective cognitive and communicative complaints. METHODS: We included 29 PD-nMCI and 11 PD-MCI patients. The HRQoL was assessed with the Parkinson's Disease Questionnaire-39 (PDQ-39): its Cognition dimension was used as a measure of subjective cognitive complaints, its Communication dimension for subjective communicative complaints, and the summary index (PDQ-39 SI) as an indicator of HRQoL. Non-parametric partial correlations between the Cognition and Communication dimensions, and the adjusted PDQ-39 SI were conducted. RESULTS: PD-MCI patients had greater subjective cognitive and communicative complaints and worse HRQoL than PD-nMCI patients. In the PD-MCI group, both subjective cognitive and communicative complaints exhibited significant direct correlations with the adjusted HRQoL scores. CONCLUSIONS: HRQoL seems to be affected in PD-MCI, and it might be influenced by greater subjective cognitive and communicative complaints. Including patient-reported outcome measures of HRQoL, and providing cognitive and speech rehabilitation, as well as psychotherapeutic strategies to face these deficits can enhance the patient-centred approach in PD.

Resting-state EEG alpha/theta ratio related to neuropsychological test performance in Parkinson's Disease.

OBJECTIVE: To determine possible associations of hemispheric-regional alpha/theta ratio (α/θ) with neuropsychological test performance in Parkinson's Disease (PD) non-demented patients. METHODS: 36 PD were matched to 36 Healthy Controls (HC). The α/θ in eight hemispheric regions was computed from the relative power spectral density of the resting-state quantitative electroencephalogram (qEEG). Correlations between α/θ and performance in several neuropsychological tests were conducted, significant findings were included in a moderation analysis. RESULTS: The α/θ in all regions was lower in PD than in HC, with larger effect sizes in the posterior regions. Right parietal, and right and left occipital α/θ had significant positive correlations with performance in Judgement of Line Orientation Test (JLOT) in PD. Adjusted moderation analysis indicated that right, but not left, occipital α/θ influenced the JLOT performance related to PD. CONCLUSIONS: Reduction of the occipital α/θ, in particular on the right side, was associated with visuospatial performance impairment in PD. SIGNIFICANCE: Visuospatial impairment in PD, which is highly correlated with the subsequent development of dementia, is reflected in α/θ in the right posterior regions. The right occipital α/θ may represent a useful qEEG marker for evaluating the presence of early signs of cognitive decline in PD and the subsequent risk of dementia.

Aporte de la 18F-FDG PET/TC en la enfermedad de Creutzfeldt-Jakob esporádica / Contribution of the 18F-FDG PET/CT IN sporadic Creutzfeldt-Jakob disease

La enfermedad de Creutzfeldt-Jakob esporádica (ECJe) es un trastorno neurodegenerativo transmisible, extremadamente raro, caracterizado por demencia rápidamente progresiva. En la tomografía por emisión de positrones con 18F-fluoro-2-desoxi-D-glucosa (18F-FDG-PET/TC) de estos pacientes se ha descrito hipometabolismo cortical bilateral parietal, frontal y occipital, sin alteraciones en el cerebelo ni en los ganglios basales, lo que podría contribuir con el diagnóstico diferencial de demencia rápidamente progresiva. Se presenta el caso de un hombre de 75 años de edad, con antecedente de cáncer de próstata y trastorno afectivo bipolar, con cuadro de dos semanas de cambios comportamentales y anímicos, déficit cognitivo, alucinaciones visuales y auditivas y desorientación espacial con rápida progresión. Posteriormente, el paciente presenta marcha lenta, temblor en miembros inferiores y Babinski derecho. La resonancia magnética (RM) cerebral mostró restricción a la difusión en la corteza frontal y temporal bilateral y giro del cíngulo, con sospecha diagnóstica de síndrome paraneoplásico versus enfermedad por priones. La 18F-FDG-PET/TC demostró hipometabolismo en la corteza frontal bilateral y lóbulo temporal y parietal derechos. La medición de la proteína 14-3-3, proteína T-Tau y conversión de proteína priónica inducida por agitación en tiempo real (RT-QUIC) en líquido cefalorraquídeo confirmó el diagnóstico de enfermedad por priones.

Sporadic Creutzfeldt-Jakob disease (sCJD) is an extremely rare transmissible neurodegenerative disorder characterized by rapidly progressive dementia. 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET/CT) in these patients has described bilateral parietal, frontal and occipital cortical hypometabolism, without alterations in the cerebellum or basal ganglia, which could contribute to the differential diagnosis of rapidly progressive dementia. We present the case of a 75-year-old man with a history of prostate cancer and bipolar affective disorder, with a two-week picture of behavioral and mood changes, cognitive deficit, visual and auditory hallucinations and spatial disorientation with rapid progression. Subsequently, the patient presented slow gait, tremor in lower limbs and right Babinski. Brain magnetic resonance imaging (MRI) showed diffusion restriction in the bilateral frontal and temporal cortex and cingulate gyrus, with diagnostic suspicion of paraneoplastic syndrome versus prion disease. 18F-FDG-PET/CT showed hypometabolism in the bilateral frontal cortex and right temporal and parietal lobe. Measurement of 14-3-3 protein, T-Tau protein and real-time shake-induced prion protein conversion (RT-QUIC) in cerebrospinal fluid confirmed the diagnosis of prion disease.

Miastenia gravis posterior a trasplante renal / Myasthenia gravis after kidney transplantation

No disponible

Síndrome de desmielinización osmótica. presentación de un caso y revisión de tema / Osmotic demyelination syndrome. case report and review

Resumen: El síndrome de desmielinización osmótica es una complicación neurológica poco frecuente. Se ha descrito, principalmente en pacientes que se les realiza correcciones rápidas en sus niveles de sodio sérico, por lo cual, siempre se debe ser cauto a la hora de corregir trastornos hidroelectrolíticos en los pacientes que consultan al servicio de urgencia. Sin embargo, se han reportado casos asociados de desmielinización osmótica sin correcciones de hiponatremias, por lo que se debe tener un bajo umbral diagnóstico para sospecharlo, por las consecuencias neurológicas asociadas y la ausencia de tratamiento efectivo. A continuación presentamos un caso clínico de una paciente que presentó un episodio de desmielinización osmótica extrapontica al parecer sin secuelas. Adicionalmente se hace una revisión completa del tema.

Abstract: Osmotic demyelination syndrome is a rare neurological complication. It has mainly been described in patients who have undergone rapid corrections in serum sodium levels. It should always be cautious when correcting electrolyte disorders in patients presenting to the emergency service. However, it has been reported associated cases of osmotic demyelination without hyponatremia corrections.It is necessary to have a low threshold for suspecting the diagnosis of osmotic demyelination syndrome by the neurological consequences associated and the absence of effective treatment. Here, we presented a case report of a patient with an episode of extrapontine osmotic demyelination, apparentlywithout consequences. In addition, a full review of the topic is made.